Analystreport

Caladrius Biosciences, Inc. (NASDAQ: CLBS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Caladrius Biosciences, Inc.  (CLBS) 
Last caladrius biosciences, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: caladrius.com/investors/overview